NRIX Nurix Therapeutics, Inc.

NASDAQ

$22.99

Nurix Therapeutics, Inc. (NRIX) Earnings News

Earnings press releases, previews and reviews for Nurix Therapeutics, Inc. (NRIX), newest first.

Thursday July 9, 2026 4:01 PM ET

Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thursday June 11, 2026 7:00 AM ET

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

Wednesday April 8, 2026 6:00 AM ET

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update